Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
Recommended Citation
Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear DE, Virani S, Morris PB. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2016; 134(21):468-468.
Document Type
Article
Publication Date
11-22-2016
Publication Title
Circulation
Medical Subject Headings
American Heart Association; Cardiovascular Diseases; Clinical Decision-Making; Comorbidity; Consensus; Drug Interactions; Dyslipidemias; Evidence-Based Medicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Polypharmacy; Risk Assessment; Risk Factors; Treatment Outcome; United States
PubMed ID
27754879
Volume
134
Issue
21
First Page
468
Last Page
468
